Literature DB >> 1702736

Correlation between endotoxin-neutralizing capacity of human plasma as tested by the limulus-amebocyte-lysate-test and plasma protein levels.

D Berger1, S Schleich, M Seidelmann, H G Beger.   

Abstract

In the present study the endotoxin-neutralizing capacity of human plasma obtained from healthy volunteers was determined by use of the limulus-amebocyte-lysate test. The extent of the endotoxin-neutralizing capacity which showed a very broad variation was correlated to the plasma levels of some proteins which are believed to contribute to endotoxin transport and detoxification. The plasma levels of alpha 2-macroglobulin and transferrin, the major transport proteins, as well as the levels of IgG, IgA and IgM and apoprotein A were not significantly correlated to the neutralizing capacity. Only the apoprotein B, the major apoprotein of the low density lipoprotein fraction shows a significant correlation. Together with previously published results it should be concluded that low density lipoproteins are involved in the endogenous endotoxin-neutralizing reaction occurring in human plasma, at least when high doses of endotoxin are administered. Nevertheless the endotoxin-neutralizing reaction seems to be a very complex multistep process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702736     DOI: 10.1016/0014-5793(90)80803-q

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Effect of hyperbaric oxygen and ulinastatin on plasma endotoxin, soluble CD14, endotoxin-neutralizing capacity and cytokines in acute necrotizing pancreatitis.

Authors:  Jing Hou; Ming-Wei Zhu; Xiu-Wen He; Jun-Ming Wei; Yong-Guo Li; Da-nian Tang
Journal:  Can J Surg       Date:  2010-08       Impact factor: 2.089

2.  Effects of postoperative enteral immune-enhancing diet on plasma endotoxin level, plasma endotoxin inactivation capacity and clinical outcome.

Authors:  Guoxiang Yao; Xinbo Xue; Xingpei Liu; Jianming Wang; Jiaqin Qian
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

3.  Change in plasma endotoxin titres and endotoxin neutralizing activity in the perioperative period.

Authors:  T Imai; T Shiga; N Saruki; K Nishikawa; T Fujita; Y Morishita
Journal:  Can J Anaesth       Date:  1996-08       Impact factor: 5.063

4.  Lipoprotein(a) inhibits lipopolysaccharide-induced tumor necrosis factor alpha production by human mononuclear cells.

Authors:  M G Netea; N de Bont; P N Demacker; B J Kullberg; L E Jacobs; T J Verver-Jansen; A F Stalenhoef; J W Van der Meer
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Effect of major abdominal surgery on endotoxin release and expression of Toll-like receptors 2/4.

Authors:  Klaus Buttenschoen; Marion E Schneider; Katja Utz; Marko Kornmann; Hans G Beger; Daniela Carli Buttenschoen
Journal:  Langenbecks Arch Surg       Date:  2008-06-11       Impact factor: 3.445

6.  In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins.

Authors:  K Emancipator; G Csako; R J Elin
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

7.  Endotoxin levels in sera of elderly individuals.

Authors:  T Goto; S Edén; G Nordenstam; V Sundh; C Svanborg-Edén; I Mattsby-Baltzer
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

8.  Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B.

Authors:  W A Flegel; F Müller; W Däubener; H G Fischer; U Hadding; H Northoff
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

9.  Vitellogenin recognizes cell damage through membrane binding and shields living cells from reactive oxygen species.

Authors:  Heli Havukainen; Daniel Münch; Anne Baumann; Shi Zhong; Øyvind Halskau; Michelle Krogsgaard; Gro V Amdam
Journal:  J Biol Chem       Date:  2013-07-28       Impact factor: 5.157

Review 10.  Endotoxemia: methods of detection and clinical correlates.

Authors:  J C Hurley
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.